{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:12:05Z","timestamp":1794453125319,"version":"4.9.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>\n                      To compare low-density fractional microablative carbon dioxide (CO\n                      <jats:sub>2<\/jats:sub>\n                      ) laser treatment with topical clobetasol propionate for symptom control in women with vulvar lichen sclerosus (LS).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a prospective, randomized, open-label trial that included women with symptomatic LS. Participants were randomized to three courses of CO\n                      <jats:sub>2<\/jats:sub>\n                      laser treatment every 3 weeks or to a 3-month regimen of tapered topical clobetasol propionate 0.05%. The primary outcome was the change in the BIP (burn-itch-pain) score (range 0\u201330) from baseline to 3 months. Secondary outcomes included physician-rated visual improvement and overall improvement, and disease-specific quality of life (QOL). Ninety participants per group provided 90% power to detect a 2-point between-group BIP score difference (SD 4; 2-sided \u03b1=0.05). Analyses were intention-to-treat. Prespecified multivariable linear regression adjusted for baseline symptom severity, age, body mass index (BMI), smoking status, previous corticosteroid use, and disease duration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Between November 2021 and March 2025, 245 women were randomized (laser: n=123; clobetasol propionate: n=122). At 3 months, symptom improvement was greater in the laser group (median \u0394BIP score \u22128 [IQR \u221213 to\u22123]) than in the clobetasol propionate group (\u22125 [IQR, \u221210.75 to 0];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.007). In the multivariable analysis, laser treatment remained independently associated with greater symptom improvement (adjusted \u03b2, \u22122.90; 95% CI, \u22124.64 to \u22121.15;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.001). Physician-rated visual improvement and overall improvement, and disease-specific QOL change favored laser therapy. Both treatments were generally well tolerated, with no serious treatment-related adverse events. During an exploratory postrandomization phase after the 3-month primary endpoint assessment, participants could choose to cross over to the alternative treatment. Patients who crossed over from clobetasol propionate to laser experienced additional symptom improvement from 3 to 6 months. Results were robust to sensitivity analyses for missing outcome data.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>\n                      Laser treatment resulted in greater symptom improvement than clobetasol propionate therapy for women with vulvar LS. Sequential treatment with clobetasol propionate followed by CO\n                      <jats:sub>2<\/jats:sub>\n                      laser may further improve clinical symptoms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT05010421.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006326","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:01:24Z","timestamp":1780002084000},"page":"451-461","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Laser Treatment Compared with Topical Clobetasol for Lichen Sclerosus"],"prefix":"10.1097","volume":"148","author":[{"given":"Julia M.","family":"Hecken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Shoham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens B.","family":"Tempfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther A.","family":"Rezniczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"R1-20260917","first-page":"55","article-title":"Vulvar Lichen Sclerosus et Atrophicus","volume":"8","author":"Nair","year":"2017","journal-title":"J Midlife Health"},{"key":"R2-20260917","first-page":"477","article-title":"Prevalence of vulvar lichen sclerosus in a general gynecology practice","volume":"50","author":"Goldstein","year":"2005","journal-title":"J Reprod Med"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40257-018-0364-7","article-title":"Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists","volume":"19","author":"Lee","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamadermatol.2015.0643","article-title":"Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women","volume":"151","author":"Lee","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/ijc.30621","article-title":"Lichen sclerosus and risk of cancer","volume":"140","author":"Halonen","year":"2017","journal-title":"Int J Cancer"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"107767","DOI":"10.1016\/j.maturitas.2023.04.010","article-title":"Genital and extragenital oncological risk in women with vulvar lichen sclerosus: a multi-center Italian study","volume":"175","author":"Preti","year":"2023","journal-title":"Maturitas"},{"key":"R7-20260917","first-page":"992","article-title":"Corticosteroids for vulvar lichen sclerosus","volume":"44","author":"Edwards","year":"1999","journal-title":"J Reprod Med"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJWH.S191200","article-title":"Vulvar lichen sclerosus: current perspectives","volume":"12","author":"Krapf","year":"2020","journal-title":"Int J Womens Health"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/13697137.2017.1343295","article-title":"Lichen sclerosus in women: a review","volume":"20","author":"P\u00e9rez-L\u00f3pez","year":"2017","journal-title":"Climacteric"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00128071-200405020-00005","article-title":"Vulvar lichen sclerosus pathophysiology and treatment","volume":"5","author":"Smith","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/lsm.23669","article-title":"A prospective pilot study to assess for histologic changes on vulvar biopsies in postmenopausal women with lichen sclerosus treated with fractionated CO2 laser therapy","volume":"55","author":"Dieter","year":"2023","journal-title":"Lasers Surg Med"},{"key":"R12-20260917","first-page":"1678","article-title":"Efficacy of fractional CO2 laser therapy in improving symptoms and quality of life in women with refractory vulvar lichen sclerosus: a prospective observational study","volume":"14","author":"Gil-Villalba","year":"2024","journal-title":"Life (Basel)"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"e70098","DOI":"10.1111\/jog.70098","article-title":"Retrospective study on CO2 laser for second-line treatment of vulvar lichen sclerosus","volume":"51","author":"Siliquini","year":"2025","journal-title":"J Obstet Gynaecol Res"},{"key":"R14-20260917","first-page":"2146","article-title":"Laser therapy for vulvar lichen sclerosus, a systematic review","volume":"13","author":"Gil-Villalba","year":"2023","journal-title":"Life (Basel)"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/AOG.0000000000004409","article-title":"Fractionated carbon dioxide laser for the treatment of vulvar lichen sclerosus: a randomized controlled trial","volume":"137","author":"Mitchell","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/AOG.0000000000004332","article-title":"Clobetasol compared with fractionated carbon dioxide laser for lichen sclerosus: a randomized controlled trial","volume":"137","author":"Burkett","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jogc.2019.01.023","article-title":"Efficacy of non-ablative laser therapy for lichen sclerosus: a randomized controlled trial","volume":"41","author":"Bizjak Ogrinc","year":"2019","journal-title":"J Obstet Gynaecol Can"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/1471-0528.17737","article-title":"Nd:YAG\/Er:YAG dual laser compared with topical steroid to treat vulvar lichen sclerosus: a randomised controlled trial","volume":"131","author":"Zivanovic","year":"2024","journal-title":"BJOG"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/nau.23931","article-title":"The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS\/ISSVD best practice consensus document","volume":"38","author":"Preti","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/ajd.13197","article-title":"The vulval disease quality of life index in women with vulval lichen sclerosus correlates with clinician and symptom scores","volume":"61","author":"Felmingham","year":"2020","journal-title":"Australas J Dermatol"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput Sci Eng"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006326","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:00:26Z","timestamp":1789675226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006326"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006326","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"2026-01-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}